查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771678

胜肽合成市場規模、佔有率、趨勢分析報告：按產品、應用、技術、最終用途、地區和細分市場預測，2025 年至 2033 年

Peptide Synthesis Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

胜肽合成市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，預計到2033年，全球胜肽合成市場規模將達到18.406億美元，2025年至2033年的複合年成長率為7.71%。針對肽療法開發的重大研究和技術創新將在不久的將來推動市場成長。此外，肽合成技術的不斷進步預計將為在該市場企業發展的公司提供豐厚的利潤機會。

近年來，對客製化胜肽合成的需求激增，許多公司都致力於提供與客製化胜肽合成相關的產品和服務。例如，總部位於英國的Almac集團就提供研究應用的胜肽合成服務。客製化胜肽需求的不斷成長以及市場格局的演變，為市場成長提供了豐厚的利潤機會。供應商正在擴大產能，以滿足研究和治療領域對高品質胜肽日益成長的需求。

製藥公司專注於開發新型生技藥品，並將胜肽類藥物從研發管線階段推進至商業化規模，將進一步促進市場成長。越來越多的研究活動致力於探索高品質胜肽和胜肽庫在疫苗開發和生物標記發現中的潛力，這為全球胜肽合成市場的收益做出了巨大貢獻。此外，隨著穩定性和藥物動力學特性增強的改性胜肽（GMP肽）的市場引入，預計在整個預測期內，市場將保持兩位數的成長。

近年來，隨著心血管疾病和代謝疾病患者數量的大幅增加，治療性胜肽的發展取得了顯著成長，這極大地促進了活性胜肽的發現，進一步刺激了市場需求。

肽合成市場報告重點

  • 試劑和消耗品等產品部分在胜肽合成市場佔據主導地位，2024 年的收益佔有率為 47.97%。預計設備部分在預測期內將實現顯著的複合年成長率。
  • 液相肽合成 (LPPS) 技術領域在胜肽合成市場佔據主導地位，2024 年的收益佔有率為 44.04%。在胜肽合成市場中，混合技術領域預計在預測期內將實現最快的複合年成長率。
  • 治療藥物將佔據市場主導地位，2024 年的收益佔有率將達到 70.35%。在胜肽合成市場中，診斷應用領域預計在預測期內將實現最快的複合年成長率。
  • 預計製藥和生物技術公司將引領市場，到 2024 年將佔據 66.74% 的收益佔有率。在胜肽合成產業的最終用途領域，合約研究和開發組織 (CDMOs 和 CRO) 預計在預測期內將實現最快的複合年成長率。
  • 2024 年，北美胜肽合成佔據全球市場主導地位，收益佔有率最大，為 38.95%。預計在預測期內，亞太肽合成市場將以 9.33% 的複合年成長率實現最快成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場血統
    • 母市場分析
    • 輔助市場分析
  • 胜肽合成－市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 市場分析工具
    • 波特五力分析
    • SWOT分析：依因素（政治/法律、經濟、技術）
    • COVID-19影響分析

第4章胜肽合成市場：產品業務分析

  • 產品細分儀表板
  • 2024 年和 2033 年全球胜肽合成市場產品變化分析
  • 全球胜肽合成市場規模及趨勢分析（按產品，2021-2033）
  • 裝置
  • 試劑和耗材
  • 服務

第5章胜肽合成市場：技術業務分析

  • 技術細分儀表板
  • 2024年及2033年全球胜肽合成市場趨勢分析（按技術）
  • 2021-2033 年全球胜肽合成市場規模及趨勢分析（按技術）
  • 固相胜肽合成（SPPS）
  • 液相肽合成（LPPS）
  • 混合技術

第6章胜肽合成市場：應用業務分析

  • 應用程式細分儀表板
  • 2024年及2033年全球胜肽合成市場應用趨勢分析
  • 全球胜肽合成市場規模及應用趨勢分析（2021-2033）
  • 治療
  • 診斷
  • 調查

7. 胜肽合成市場：最終用途業務分析

  • 最終用途細分儀表板
  • 2024 年和 2033 年全球胜肽合成市場最終用途變化分析
  • 2021-2033 年全球胜肽合成市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • CDMO/CRO
  • 學術研究所

第8章胜肽合成市場：按產品、技術、應用和最終用途的區域估計和趨勢分析

  • 區域市場儀表板
  • 2024 年及 2033 年區域市場佔有率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GenScript
    • Bachem Holding AG
    • Biotage
    • Creative Diagnostics
    • PolyPeptide Group
    • Syngene International Limited
    • Puresynth Research Chemicals Pvt Ltd.
    • Lonza
Product Code: GVR-3-68038-697-4

Peptide Synthesis Market Growth & Trends:

The global peptide synthesis market size is expected to reach USD 1,840.6 million by 2033, registering a CAGR of 7.71% from 2025 to 2033, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

Peptide Synthesis Market Report Highlights:

  • The reagents and consumables in the product segment dominated the peptide synthesis market with a revenue share of 47.97% in 2024. The equipment segment is expected to register a significant CAGR during the forecast period.
  • The technology segment's liquid phase peptide synthesis (LPPS) dominated the peptide synthesis market with a revenue share of 44.04% in 2024. The hybrid technology segment in the peptide synthesis market is expected to register the fastest CAGR during the forecast period
  • Therapeutics dominated the market with a revenue share of 70.35% in 2024. The diagnosis application segment in the peptide synthesis market is expected to register the fastest CAGR during the forecast period.
  • Pharmaceutical and biotechnology companies led the market with a revenue share of 66.74% in 2024. The Contract Development & Manufacturing Organization & Contract Research Organization (CDMOs & CROs) in the end-use segment in the peptide synthesis industry are expected to register the fastest CAGR during the forecast period.
  • North America peptide synthesis dominated the global market with the largest revenue share of 38.95% in 2024. The peptide synthesis market in Asia Pacific is expected to register the fastest growth, with a CAGR of 9.33% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Peptide Synthesis- Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Peptide Synthesis Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Peptide Synthesis Market Product Movement Analysis, 2024 & 2033
  • 4.3. Global Peptide Synthesis Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Global Equipment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Peptide Synthesizers
      • 4.4.2.1. Global Peptide Synthesizers Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Lyophilizers
      • 4.4.3.1. Global Lyophilizers Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Chromatography Equipment
      • 4.4.4.1. Global Chromatography Equipment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Global Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reagents & Consumables
    • 4.5.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Resins
      • 4.5.2.1. Global Resins Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Amino Acids
      • 4.5.3.1. Global Amino Acids Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Coupling Reagents
      • 4.5.4.1. Global Coupling Reagents Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Dyes & Fluorescent Labeling Reagents
      • 4.5.5.1. Global Dyes & Fluorescent Labeling Reagents Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Global Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
      • 4.6.1.1. Global Services Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Peptide Synthesis Market: Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Global Peptide Synthesis Market Technology Movement Analysis, 2024 & 2033
  • 5.3. Global Peptide Synthesis Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Solid Phase Peptide Synthesis (SPPS)
    • 5.4.1. Global Solid Phase Peptide Synthesis (SPPS) Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Liquid Phase Peptide Synthesis (LPPS)
    • 5.5.1. Global Liquid Phase Peptide Synthesis (LPPS) Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Hybrid Technology
    • 5.6.1. Global Hybrid Technology Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Peptide Synthesis Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Peptide Synthesis Market Application Movement Analysis, 2024 & 2033
  • 6.3. Global Peptide Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Therapeutics
    • 6.4.1. Global Therapeutics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Cancer
      • 6.4.2.1. Global Cancer Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Metabolic
      • 6.4.3.1. Global Metabolic Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Cardiovascular Disorder
      • 6.4.4.1. Global Cardiovascular Disorder Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Respiratory
      • 6.4.5.1. Global Respiratory Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. GIT (Gastrointestinal Disorders)
      • 6.4.6.1. Global GIT (Gastrointestinal Disorders) Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Infectious Disease
      • 6.4.7.1. Global Infectious Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Pain
      • 6.4.8.1. Global Pain Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Dermatology
      • 6.4.9.1. Global Dermatology Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.10. CNS
      • 6.4.10.1. Global CNS Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.11. Renal
      • 6.4.11.1. Global Renal Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.12. Others
      • 6.4.12.1. Global Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Diagnosis
    • 6.5.1. Global Diagnosis Peptide Synthesis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Research
    • 6.6.1. Global Research Peptide Synthesis Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Peptide Synthesis Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Peptide Synthesis Market End Use Movement Analysis, 2024 & 2033
  • 7.3. Global Peptide Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5. CDMOs/CROs
    • 7.5.1. Global CDMOs/CROs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic and Research Institutions
    • 7.6.1. Global Academic and Research Institutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Peptide Synthesis Market: Regional Estimates & Trend Analysis by Product, Technology, Application, and End Use

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Regulatory framework
      • 8.3.2.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Target disease prevalence
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Regulatory framework
      • 8.3.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Target disease prevalence
      • 8.3.4.3. Competitive scenario
      • 8.3.4.4. Regulatory framework
      • 8.3.4.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Target disease prevalence
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Regulatory framework
      • 8.4.2.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Target disease prevalence
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Regulatory framework
      • 8.4.3.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Target disease prevalence
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Regulatory framework
      • 8.4.4.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Target disease prevalence
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Regulatory framework
      • 8.4.5.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Target disease prevalence
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Regulatory framework
      • 8.4.6.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Target disease prevalence
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Regulatory framework
      • 8.4.7.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Target disease prevalence
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Regulatory framework
      • 8.4.8.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Target disease prevalence
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Regulatory framework
      • 8.4.9.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Target disease prevalence
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Regulatory framework
      • 8.5.2.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Target disease prevalence
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Regulatory framework
      • 8.5.3.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Target disease prevalence
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Regulatory framework
      • 8.5.4.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Target disease prevalence
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Regulatory framework
      • 8.5.5.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Target disease prevalence
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Regulatory framework
      • 8.5.6.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Target disease prevalence
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Regulatory framework
      • 8.5.7.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Target disease prevalence
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Regulatory framework
      • 8.6.2.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Target disease prevalence
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Regulatory framework
      • 8.6.3.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Target disease prevalence
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Regulatory framework
      • 8.7.2.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Target disease prevalence
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Regulatory framework
      • 8.7.3.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Target disease prevalence
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Regulatory framework
      • 8.7.4.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Target disease prevalence
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Regulatory framework
      • 8.7.5.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Technology benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Technology benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. GenScript
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Technology benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Bachem Holding AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Technology benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Biotage
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Technology benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Creative Diagnostics
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Technology benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. PolyPeptide Group
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Technology benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Syngene International Limited
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Technology benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Puresynth Research Chemicals Pvt Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Technology benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Lonza
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Technology benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 5 Global Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 6 Global Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 7 Global Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 8 Global Peptide Synthesis Market, By region, 2021 - 2033 (USD Million)
  • Table 9 North America Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 10 North America Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 11 North America Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 12 North America Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 13 North America Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 14 U.S. Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 15 U.S. Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 17 U.S. Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 18 Canada Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 19 Canada Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 21 Canada Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 22 Mexico Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 23 Mexico Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 25 Mexico Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 26 Europe Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 27 Europe Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 28 Europe Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 30 Europe Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 31 UK Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 32 UK Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 33 UK Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 34 UK Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 35 Germany Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 36 Germany Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 38 Germany Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 39 France Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 40 France Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 41 France Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 42 France Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 43 Spain Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 44 Spain Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 45 Spain Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 46 Spain Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 47 Italy Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 48 Italy Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 49 Italy Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 50 Italy Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 51 Denmark Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 52 Denmark Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 53 Denmark Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 54 Denmark Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 55 Norway Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 56 Norway Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 58 Norway Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 59 Sweden Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 60 Sweden Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 61 Sweden Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 62 Sweden Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 67 Asia Pacific Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 68 China Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 69 China Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 70 China Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 71 China Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 72 Japan Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 73 Japan Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 74 Japan Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 75 Japan Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 76 India Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 77 India Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 78 India Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 79 India Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 80 South Korea Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 81 South Korea Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 82 South Korea Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 83 South Korea Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 84 Australia Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 85 Australia Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 86 Australia Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 87 Australia Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 88 Thailand Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 89 Thailand Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 90 Thailand Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 91 Thailand Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 92 Latin America Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 93 Latin America Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 94 Latin America Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 96 Latin America Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 97 Brazil Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 98 Brazil Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 100 Brazil Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 101 Argentina Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 102 Argentina Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 104 Argentina Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 105 MEA Peptide Synthesis Market, By country, 2021 - 2033 (USD Million)
  • Table 106 MEA Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 107 MEA Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 108 MEA Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 109 MEA Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 110 South Africa Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 111 South Africa Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 113 South Africa Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 114 UAE Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 115 UAE Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 116 UAE Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 117 UAE Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 118 Saudi Arabia Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 119 Saudi Arabia Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 120 Saudi Arabia Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 121 Saudi Arabia Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Peptide Synthesis Market, By product, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Peptide Synthesis Market, By technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Peptide Synthesis Market, By application, 2021 - 2033 (USD Million)
  • Table 125 Kuwait Peptide Synthesis Market, By end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Peptide synthesis market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Peptide synthesis market: product outlook key takeaways
  • Fig. 13 Peptide synthesis market: product movement analysis
  • Fig. 14 Global equipment market, 2021 - 2033 (USD Million)
  • Fig. 15 Global reagents & consumables market, 2021 - 2033 (USD Million)
  • Fig. 16 Global services market, 2021 - 2033 (USD Million)
  • Fig. 17 Peptide synthesis market: Technology outlook and key takeaways
  • Fig. 18 Peptide synthesis market: Technology movement analysis
  • Fig. 19 Global solid phase Peptide Synthesis (SPPS) market, 2021 - 2033 (USD Million)
  • Fig. 20 Global liquid phase Peptide Synthesis (LPPS) market, 2021 - 2033 (USD Million)
  • Fig. 21 Global hybrid technology market, 2021 - 2033 (USD Million)
  • Fig. 22 Peptide synthesis market: application outlook and key takeaways
  • Fig. 23 Peptide synthesis market: application movement analysis
  • Fig. 24 Global Therapeutics market, 2021 - 2033 (USD Million)
  • Fig. 25 Global Diagnosis market, 2021 - 2033 (USD Million)
  • Fig. 26 Global research applications market, 2021 - 2033 (USD Million)
  • Fig. 27 Peptide Synthesis market: End-use outlook and key takeaways
  • Fig. 28 Peptide Synthesis market: End-use movement analysis
  • Fig. 29 Global pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 30 Global CDMOs & CROs market, 2021 - 2033 (USD Million)
  • Fig. 31 Global academic & research institutes market, 2021 - 2033 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Mexico Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Europe Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Germany Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 UK Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 France Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Italy Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Spain Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Market scenario
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Regulatory framework
  • Fig. 57 Key country dynamics
  • Fig. 58 Norway Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Regulatory framework
  • Fig. 60 Key country dynamics
  • Fig. 61 Sweden Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Regulatory framework
  • Fig. 63 Asia Pacific Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Japan Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 India Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Australia Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Korea Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Brazil Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 MEA Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Africa Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Saudi Arabia Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Kuwait Peptide Synthesis market estimates and forecasts, 2021 - 2033 (USD Million)